Mon, Apr 24, 2017 | updated 02:58 PM IST

6-months clinical trial data finds Indian thin strut fully dissolvable stent to be safe

Updated: Nov 02, 2016 10:34 IST      
6-months clinical trial data finds Indian thin strut fully dissolvable stent to be safe

New Delhi [India], Nov2 (ANI): Findings of the six month clinical trial on the first thin strut fully dissolvable stent in the world, developed in India, were unveiled at the prestigious main arena, Late Breaking Clinical Trials/First Report Investigations at the Cardiovascular Therapeutics (TCT) 2016, Washington DC on October 31.

The TCT is the biggest and best regarded meeting of interventional cardiologists in the world. This was a proud moment for India, as the data was presented by the eminent interventional cardiologist Dr Ashok Seth, Chairman Fortis Escorts Heart Institute, who was the principal investigator of the study.

The study titled MeRes-1 is the first-in-man study of the novel thin-strut PLLA-based sirolimus-eluting bioresorbable vascular stent (MeRes100). It considered Six-Month Clinical, Angiographic, Intravascular ultrasound (IVUS), and Optical coherence tomography (OCT) results in patients with Coronary Artery Disease.

Presenting the findings of the study, Dr. Seth said, "This is a big day for India and the 'Make in India' program. It also reveals to the world that our Indian device industry has the ability to be innovative, creative and support high quality research. The innovative design of the MeRes100 scaffold developed in India addresses some of the limitations of currently available Bio Resorbable Stents (dissolvable stents) and may have higher success and lower complication rates in the long term. It would also cost much lesser than the currently available dissolvable stents and therefore give more benefit to higher number of patients. The MeRes-1, first-in-man study demonstrates that this new generation thinner strut sirolimus eluting BRS is both safe and effective at six months. These encouraging results provide the basis for further studies using wider range of length and sizes in more complex and larger patient population."

The MeRes100 is a low profile 100µm thin strut PLLA based BRS with a unique hybrid design featuring open cells at the center and closed cells at the edges resulting in improved track-ability and access to side branches. It also has enhanced visibility with three circumferential radio opaque markers at each end.

In this prospective, multicenter, single arm trial of MeRes100 BRS, a total of 108 patients (116 lesions) were enrolled at 16 Indian sites from May 2015 to April 2016.

The primary end-point was Major Adverse Cardiac Events (MACE), a composite of cardiac death, myocardial infarction, Ischaemia Driven Target Lesion Revascularization (ID-TLR), and Ischaemia Driven Target Vessel Revascularization (ID-TVR) at six months. The secondary end-point was scaffold thrombosis at six months.

The study found no MACE or stent thrombosis (ST) after the deployment of the scaffold up to six month follow-up.

Quantitative Coronary Analysis (QCA) data at six months demonstrated very favourable in scaffold late lumen loss of 0.15±0.26mm. Intravascular ultrasound (IVUS) and Optical coherence tomography (OCT) analysis showed no scaffold recoil and near complete strut coverage (99.3percent) with neointima.

The TCT is the annual scientific symposium of the Cardiovascular Research Foundation (CRF) featuring a number of first report investigations on novel stents that could become the next generation of bioresorbable stents in patients.

"Bioresorbable stents (dissolvable stents) have the potential to be greatly impactful in the treatment of coronary artery disease, and it is exciting to see these first report investigations of several new and novel stents advancing the technology forward," said Ajay Kirtane, , a Co-Director of TCT.

"These results give us the first insights into their safety and efficacy, but larger randomized trials are necessary in order to establish their role in clinical practice," he added. (ANI)

Washington D.C. [USA], April 24 (ANI): Due to increasing deaths because of prostate cancer among men, US researchers have suggested a special screening more frequently and at an early age to avoid the development of preclinical prostate cancer - that is not symptomatic - to advanced stages.

Full Story >>

New York [U.S.], Apr. 24 (ANI): Still downing gallons of diet soda despite knowing that it wrecks your body? Maybe the knowledge of artificially sweetened beverages taking a toll on your brain as well ought to make an impact on your unhealthy habit.

Full Story >>

Washington D.C. [USA], Apr 23 (ANI): A recent study has demonstrated that in the general population, central obesity, insulin resistance, diabetes, lipid abnormalities and high alcohol consumption were the strongest predictors of severe liver disease.

Full Story >>

Breastmilk may help detect your cancer risk

Updated: Apr 23, 2017 11:50 IST

Washington D.C. [USA], Apr 23 (ANI): Breastmilk might offer clues about a woman's cancer risk, according to a recent research.

Full Story >>

Soon, new weapon in war against obesity

Updated: Apr 23, 2017 11:14 IST

Washington D.C. [USA], Apr 23 (ANI): A team of scientists has uncovered a potential approach to combat obesity.

Full Story >>

Turns out, being obese is worse than smoking

Updated: Apr 23, 2017 10:52 IST

Washington D.C. [USA], Apr 23 (ANI): You may want to shed those extra kilos as a recent study has found obesity as a top cause of preventable life-years lost.

Full Story >>

Washington D.C. [USA], Apr 23 (ANI): Testing for molecular markers in the urine of kidney transplant patients could reveal whether the transplant is failing and why, according to a recent research.

Full Story >>

Washington D.C. [USA], Apr 23 (ANI): People with drug-resistant bacteria in their urine or stool samples are at an increased risk of developing Sepsis, a bloodstream infection that is also resistant to certain antibiotics, according to a recent study.

Full Story >>

Move over contact lenses, LASIK is better

Updated: Apr 22, 2017 18:05 IST

Washington D.C. [USA], April 22 (ANI): Good news for those who underwent LASIK (laser-assisted in situ keratomileusis) for correction of their vision, as a recent study has found that the rate of cornea infection is lower.

Full Story >>

New Delhi [India], Apr. 22 (ANI): In today's era of booming medical advancements, the chances of survival from cancer can be increased, if it is detected at an early stage.

Full Story >>

Eman Ahmed has done miraculously well: Doctor

Updated: Apr 21, 2017 21:11 IST

Mumbai (Maharashtra) [India], Apr 21 (ANI): 36-year-old Egyptian Eman Ahmed, who was the heaviest woman in the world at 500-plus kg until a few months ago, has lost 250kg in two months after undergoing surgery here at Saifee Hospital.

Full Story >>

Let's create awareness about liver cancer!

Updated: Apr 21, 2017 17:25 IST

New Delhi [India], Apr 21 (ANI): The increasing liver disease is one of the most common diseases in the world.

Full Story >>

College blues? Turn to mindfulness

Updated: Apr 21, 2017 16:35 IST

Washington D.C. [USA], Apr 21 (ANI): Heading off to college? A recent study has suggested that mindfulness may help freshmen stress less and smile more.

Full Story >>

Washington D.C. [USA], April 21 (ANI): A team of US researchers has revealed that the traditional clinical hearing tests often fail to diagnose patients with a common form of inner ear damage, which otherwise might be detected by some behavioural tests.

Full Story >>

Washington D.C. [USA], April 21 (ANI): Canadian researchers have found that people with multiple sclerosis start showing symptoms of something wrong, five years before the onset of disease.

Full Story >>

Washington D.C. [USA], Apr 20 (ANI): You may want to stimulate your brain in early life as a recent study has found that it may help stay mentally healthy in older age.

Full Story >>

New Delhi [India], Apr 20 (ANI): A 24-year-old multiple sclerosis patient recently got another chance at life after undergoing a bone marrow transplantation.

Full Story >>

A weapon against Alzheimer's in your womb?

Updated: Apr 20, 2017 17:13 IST

Washington D.C. [USA], Apr 20 (ANI): Think your memory is starting to slip? A protein found in umbilical cord blood may help turn back the clock on mental ageing.

Full Story >>

New Delhi [India], Apr 20 (ANI): Even though 91% Indians consider health a priority and intend to make healthy changes, a study suggests that almost one-third of the population does not care to visit physicians on time.

Full Story >>

Washington D.C. [USA], April 20 (ANI): Menopausal or pre- menopausal women, aged 40-65, who experience hot flashes or excessive sweating during sleep, are at increased risk of moderate and severe depression.

Full Story >>